Gossamer Bio
GOSS
GOSS
195 hedge funds and large institutions have $585M invested in Gossamer Bio in 2025 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 69 increasing their positions, 49 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
19% more funds holding
Funds holding: 164 → 195 (+31)
2.38% more ownership
Funds ownership: 79.21% → 81.58% (+2.4%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
195
Holding in Top 10
3
Calls
$28.9M
Puts
$7.38M
Top Buyers
| 1 | +$21.9M | |
| 2 | +$15.5M | |
| 3 | +$9.16M | |
| 4 |
Goldman Sachs
New York
|
+$4.26M |
| 5 |
Two Sigma Investments
New York
|
+$3.17M |
Top Sellers
| 1 | -$8.94M | |
| 2 | -$7.54M | |
| 3 | -$6.62M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.51M |
| 5 |
Focus Partners Wealth
Boston,
Massachusetts
|
-$3.49M |
